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Little is known about monocyte differentiation in the lung mucosal environment and 
about how the epithelium shapes monocyte function. We studied the role of the soluble 
component of bronchial epithelial cells (BECs) obtained under basal culture conditions 
in innate and adaptive monocyte responses. Monocytes cultured in bronchial epithelial 
cell-conditioned media (BEC-CM) specifically upregulate CD141, CD123, and DC-SIGN 
surface levels and FLT3 expression, as well as the release of IL-1β, IL-6, and IL-10. 
BEC-conditioned monocytes stimulate naive T  cells to produce IL-17 through IL-1β 
mechanism and also trigger IL-10 production by memory T cells. Furthermore, mono-
cytes cultured in an inflammatory environment induced by the cytokines IL-6, IL-8, IL-1β, 
IL-15, TNF-α, and GM-CSF also upregulate CD123 and DC-SIGN expression. However, 
only inflammatory cytokines in the epithelial environment boost the expression of CD141. 
Interestingly, we identified a CD141/CD123/DC-SIGN triple positive population in the 
bronchoalveolar lavage fluid (BALF) from patients with different inflammatory conditions, 
demonstrating that this monocyte population exists in vivo. The frequency of this mono-
cyte population was significantly increased in patients with sarcoidosis, suggesting a 
role in inflammatory mechanisms. Overall, these data highlight the specific role that the 
epithelium plays in shaping monocyte responses. Therefore, the unraveling of these 
mechanisms contributes to the understanding of the function that the epithelium may 
play in vivo.
Keywords: bronchial epithelial cell-conditioned media, monocytes, monocyte-derived dendritic cell, Th17, 
interleukin-17, il-1β, FLT3
inTrODUcTiOn
Over the last few years, there is compelling evidence that the epithelium not only plays a role as a 
barrier but also that epithelial cells (ECs) and their microenvironment are also capable of modulating 
immune functions (1–3). An interesting aspect is the observation that the environment of lung or 
intestinal ECs generate dendritic cells (DCs) with regulatory features (4–6). However, little is known 
about the role of lung ECs soluble components in monocyte function, and essential questions remain 
open with regard to monocyte/DC differentiation (7, 8).
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Monocytes are phagocytes with an important innate immune 
response toward pathogens (9). This population is heterogeneous 
and has an important plasticity, which makes it capable of giving 
rise to different well-defined populations, such as macrophages 
or DCs in  vitro. In vivo, it has been reported that extravascular 
monocytes are able to retain their monocytic features with minimal 
differentiation and appear to support DC function (10). In spite 
of the fact that it has been difficult to properly identify monocytes 
and both cell-derivates in vivo, in the mouse model, a phenotype 
of monocyte-derived DCs (ModDCs) has been identified under 
both the steady and inflammatory states (11–14). Little is known, 
however, about human ModDCs. Human monocytes can be clas-
sified according to their expression of CD14 and CD16 (FcγR-III): 
classical (CD14+CD16−), intermediate (CD14+CD16+), and patrol-
ling (CD14dimCD16+) monocytes (9, 15). In regard to DCs, three main 
DC subsets have been described in human blood: two conventional 
DC subsets, which can be identified in the HLA-DR+CD14− fraction 
by the expression of CD1c (BDCA-1) and CD141high (BDCA-3), 
shown to originate from a common DC progenitor (16, 17), and 
the pDC subset which is identified by CD303 (BDCA-2) CD304 
(BDCA-4) and CD123bright expression. In contrast to the well-defined 
phenotypic expression of blood DCs, in human lungs, there is evi-
dence for high phenotypic heterogeneity. In addition to the BDCA 
populations, three other subpopulations can be distinguished by the 
expression of langerin, CD1a, and DC-SIGN, but these markers are 
promiscuously expressed, making it difficult to differentiate specific 
populations (18). For example, studies show that the Langerin+ 
population in lung tissues can express BDCA-1 and CD1a, but not 
BDCA-3 (18). In contrast, in the lung tissues of allergic asthma 
patients, most of the BDCA1+cDCs express BDCA-3 (19), sug-
gesting that the DC phenotype can be modulated by the epithelial 
environment. It was recently demonstrated that gene expression 
profiling and mass cytometry analysis are useful techniques for the 
identification of lineage-imprinted cell markers in human tissues, 
such as CD172α/IRF4 and XCR1/IRF8, thus allowing for a clear 
discrimination between CD1c+CD14− DC and CD141+CD14− DC 
subsets, respectively (20). In regard to ModDCs in the lungs, they 
have been poorly investigated due lack of specific markers. Recent 
studies, however, at steady state found CD1c+ cells on the HLA-
DR+CD14+ fraction in lung tissues and Bronchoalveolar lavage fluid 
(BALF). These cells were related to a subtype of ModDCs enriched 
for the gene signatures of ModDCs described in the literature, which 
includes the expression of ZBTB46, IRF4, and FLT3 genes and the 
surface markers CD206 and CD1a (21). A similar phenotype was 
described in arthritic synovial fluid, which was associated with 
inflammatory DCs by its capacity to induce Th17 cell differentia-
tion, ex vivo (22). However, for lung diseases, particularly in chronic 
inflammation, ModDCs have not yet been identified.
In the present study, we demonstrate how ECs differentially 
regulate the phenotype and function of monocytes and as a 
result stimulate IL-17/IFN-γ-producing naive T cells and IL-10-
producing memory T cells. This particular phenotype is charac-
terized by the surface expression of CD141/CD123/DC-SIGN 
and FLT3 gene expression. Furthermore, we have characterized a 
CD141/CD123/DC-SIGN triple-positive population in patients 
with sarcoidosis, which expresses IRF4, thus demonstrating that 
this phenotype increases during inflammation and may be related 
to ModDCs. Our findings contribute to the understanding of 
the mechanism by which the epithelium modulates monocyte 
function, relevant to the understanding of epithelial dysfunction 
during chronic inflammation.
MaTerials anD MeThODs
Monocyte and epithelial cell isolation  
and Preparation
PBMCs were isolated by Ficoll-Paque density gradient centrifu-
gation. Monocytes were prepared as described previously (23, 24) 
and were characterized by high expression of CD14 (more than 
86%). Differentiation of DCs from monocytes was performed as 
originally described by culturing cells in the presence of a gran-
ulocyte-macrophage colony-stimulating factor (10  ng/mL) and 
interleukin-4 (10 ng/mL) for 4 days (25). Differentiation of mac-
rophages from monocytes was performed by culturing cells in the 
presence of 100 ng/mL of macrophage colony-stimulating factor 
(Prepotech, UK) and 10  mM HEPES (AMIMED, Switzerland) 
for 7 days.
Bronchial epithelial cells (BECs) were grown from a BEAS-2B cell 
line (number CRL-9609; ATCC). Cell cultures were maintained in 
LHC-8 (Gibco, Thermo Fisher, Reinach, Switzerland) supplemented 
with 2.2 µM epinephrine (Epi) (Sigma-Aldrich, Buchs, Switzerland) 
and 0.3  nM retinoic acid (RA) (Biofluids, Gaithersburg, MD, 
USA). Before the experiments, BECs were grown in monolayers 
to 80–85% confluence in 75-cm2 culture flasks. Then, the culture 
medium was removed, and cells were washed with PBS. BECs were 
subsequently cultured in LHC-8 without Epi and RA. After 48 h, 
the bronchial epithelial cell-conditioned media (BEC-CM) was 
harvested, filtered through a 0.22-μm pore-sized filter, and frozen at 
−20°C until it was used in the experiments. For long-term storage 
BEC-CM was frozen at −80°C.
Human primary nasal epithelial cells (PNECs) were obtained 
by brushing the inferior surface of the middle turbinate of both 
nostrils using a cytological brush (Dent-o-care, London, UK) 
as described in supplemental experimental procedures. Briefly, 
cells were cultured in a bronchial epithelial basal medium 
(BEBM), (Lonza, Switzerland), until they developed into an air-
liquid interface. Afterward, BEBM was removed and replaced by 
PneumaCult™-ALI (STEMCELL Technologies™). PNEC-CM 
was obtained after culturing cells in their optimal culture condi-
tions for 48 h. Human primary alveolar epithelial cells (PAECs) 
were cultured from the tissue of patients undergoing surgical lung 
resection due to lung cancer. Lung tissue was obtained from sites 
away from the tumors. After the biopsy, the tissue was cut into 
small pieces of 1  mm3, and these were placed into pre-wetted 
25 cm2 cell culture flasks (Falcon, Corning Incorporated, USA) for 
cell sprouting. No additional coating was applied. The epithelial 
growth medium (CELLnTEC, Bern, Switzerland) was replaced 
every fourth day. AECs were grown under standard conditions 
(37°C, 21% O2, 5% CO2). PAEC-CM was obtained after culturing 
cells in their optimal culture conditions for 24 h. Subsequently, 
all harvested condition media were centrifuged at 1,200 rpm for 
10 min, filtered through a 0.22-μm pore-sized filter, and frozen 
at −80°C until they were used in the experiments.
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BalF samples
Bronchoalveolar lavage fluid (BALF) samples were obtained 
from patients undergoing bronchoscopy for medical reasons 
by the CHUV Pneumology Service. In total, 4 BALF samples 
were obtained from patients with biopsy and/or cytology proven 
adenocarcinoma, 13 from patients diagnosed with sarcoidosis, 
and 7 from patients with idiopathic or secondary interstitial pneu-
monia. All of the diseases were diagnosed based on established 
standard criteria (26–28). Flexible bronchoscopy was performed 
according to established guidelines as previously described (29, 
30). Lavage was performed in 50 mL aliquots with a total amount 
of 150–250 mL of 0.9% sterile saline. The BALF was recovered 
by gentle aspiration. Collected samples (20–30 mL) not used for 
diagnosis were filtered through a nylon mesh filter and cells were 
counted manually using trypan blue. Cells were centrifuged and 
the pellet was washed with cold HBSS. Around 1 × 106 cells were 
prepared per condition and subsequently stained with Abs or 
isotype controls for flow cytometric analysis.
Monocyte and Dc stimulation
Human monocytes or DCs (1  ×  106 cells/condition) were cul-
tured for 48 h with medium alone or with the conditioned media 
(CM) obtained from BECs or primary cells, such as PNECs and 
PAECs. In some experiments, after 24  h of culture, cells were 
stimulated with 100  ng/mL of lipopolysaccharide (LPS, DIFCO 
E. coli 055:B5) and/or with 0.5 µg/mL anti-CD141 (Miltenyi Biotec, 
Germany). Mouse IgG1 isotype control (0.5 µg/mL) (eBioscience, 
Switzerland) was used as a control. To induce an inflammatory envi-
ronment, monocytes were cultured for 48 h with medium alone or 
with BEC-CM with 1 ng/mL of the following cytokines, designated 
as the inflammatory cocktail: human recombinant IL-6 (Invitrogen, 
Reinach, Switzerland), IL-8, IL-15, IL-1β, GM-CSF (R&D System, 
Abingdon, UK), and TNF-α (Roche, Basel Switzerland). For the 
control, cells were supplemented with 100 pg/mL of IL-6 (Invitrogen, 
Switzerland) and 500 pg/mL IL-8 (R&D System, UK).
cytokine Measurements
IL-17, IL-6, IL-8, IL-1β, IL-12p70, IL-10, and TNF-α cytokines 
were measured in the Luminex Bio-Plex 200 System (Bio-Rad, 
USA), using Bio-Rad kits according to the manufacturer’s 
instructions. IL-23 was measured with a commercial ELISA kit 
(Biotest, France).
Mixed lymphocyte reaction
Naive and memory CD4 T  cells were isolated from healthy 
PBMCs by negative selection using the Naive CD4+ T Cell 
Isolation Kit II or the Memory CD4+ T Cell Isolation Kit 
(Miltenyi Biotec, Germany), respectively. Treated monocytes 
(cultured with medium alone or with BEC-CM) were co-cultured 
at a monocyte:T-cell ratio of 1:10 for 9 days, supplemented with 
IL-2 for the last 2 days and then stimulated for 5 h with PMA 
and ionomycin. Supernatants were collected and stored at −80°C 
until they were needed for cytokine measurement. Neutralizing 
experiments were performed using the following neutralizing 
antibodies: IL-1β (CRM56, Ebioscience) used at 2  µg/mL and 
IL-6R (Tocilizumab-Roche) (humanized IgG1) used at 10  µg/
mL. Human IgGκ isotope (Sigma, Switzerland) and mouse 
IgG1 isotype functional grade purified control (eBioscience, 
Switzerland) were used as controls.
Flow cytometry
Cell suspensions were stained with LIVE/DEAD® Fixable Dead 
Cell Stain (molecular probes) followed by surface staining with 
the following Abs: anti-FITC-CD1c, APC-CD141, FITC-CD123, 
PE-DC-SIGN (Miltenyi Biotec), PercPcy5.5-CD14, A700-CD11b, 
PE-CD11c, FITC-CD80, PB-CD3 (BD Bioscience) KO-CD16, 
Pe/Cy7-HLA-DR (Beckman Coulter), PE-CD163, PB-CD86, 
PB-CD56, PB-CD19 (Biolegend), CCR6 (R&D), or isotype-
matched control antibodies. In brief, cells were stained for 20 min 
at 4°C in FACS buffer and fixed in 1% paraformaldehyde. For 
intracellular staining, cells were fixed and permeabilized with 
cytofix/cytoperm (BD Bioscience) for 30 min, washed, and labeled 
by PE-IRF4 (Biolegend) in Perm/Wash buffer (BD Bioscience). 
Cell-surface fluorescence intensity was assessed on a Gallios 
flow cytometer (Beckman Coulter) and analyzed using FlowJo 
(TreeStar). The Mean Fluorescence Intensity ratio was defined as 
the ratio of specific markers to the corresponding isotype controls.
real-time Quantitative rT-Pcr
Total RNA was extracted with the RNeasy mini kit (Qiagen Inc.) 
according to the manufacturer’s instructions. cDNA was syn-
thesized using an iScript™ cDNA Synthesis Kit (Biorad, USA). 
Transcripts were quantified by the real-time quantitative PCR 
CFX96 Touch Real-Time PCR Detection System (Bio-Rad) using 
the master mix iTaq™ Universal SYBR® Green Supermix (Bio-
Rad). After amplification, Cq values were obtained using the CFX 
Manager™ software 2.1 (Bio-Rad). Relative human gene expres-
sion of ZBTB46 (qHsaCED0044323), CSF1R (qHsaCID0010604), 
FCER1A (qHsaCID0005954), IRF4 (qHsaCED0004445), FLT3 
(qHsaCID0021972), XCR1 (qHsaCED0002997), and IL1B 
(qHsaCID0022272) was assessed by normalizing gene expression 
values to those of the reference gene β-2-microglobulin (B2M) 
(qHsaCID0015347).
statistical analysis
Results are expressed as means ±  SEM. Multiple group com-
parisons were made by the analysis of variance test. Each analysis 
was followed by multiple comparisons test as mentioned in each 
figure. Comparisons between two groups were made using the 
two-tailed Student’s t-test. The statistical significance was deter-
mined using the Mann–Whitney test. P-values less than 0.05 were 
considered statistically significant. All statistical analyses were 
done with the GraphPad Prism software (GraphPad Software, 
Inc., La Jolla, CA, USA).
resUlTs
Bec-cM induced a Particular Monocyte 
Phenotype, Which is characterized by  
the expression of cD141, cD123,  
and Dc-sign
In order to analyze the effect of the epithelial soluble component 
on monocytes, isolated human monocytes were cultured for 
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48 h in supernatants obtained from human bronchial epithelial 
BEAS-2B  cells (BEC). Flow cytometry was used to analyze 
the expression of monocyte and macrophage markers, such as 
CD14, CD16, and CD163; DC markers such as, CD141, CD123, 
DC-SIGN, and CD1c; co-stimulatory molecules, such as HLA-DR, 
CD80, and CD86; myeloid markers, such as CD11b and CD11c 
(Figure 1A). Our results show that human monocytes cultured 
in  vitro spontaneously develop into a monocytic–macrophage 
phenotype as observed by the expression of CD14, CD163, 
CD11b, and CD11c, but that they also express co-stimulatory 
molecules, such as CD86 and HLA-DR. In comparison, cells 
cultured in BEC-CM, in addition to the previous markers, notice-
ably increased the expression of CD141, CD123, and DC-SIGN, 
markers that have been identified in different subpopulations of 
DCs, thus suggesting that this particular phenotype may identify 
a distinctive cell type.
Bec-cM, as well as Primary  
alveolar- or nasal epithelial  
cell-conditioned Media Modulated  
the surface Phenotype of Monocytes
In order to investigate whether the CD141/CD123/CD-SIGN 
phenotype was also detectable in DCs, monocytes were cultured 
in GM-CSF (10  ng/mL) and IL-4 (10  ng/mL) to obtain DCs. 
Figures  1B–D show that BEC-CM significantly increased the 
expression of CD141, CD123, and DC-SIGN in monocytes, in 
contrast to DCs where no upregulation of any of these receptors 
was observed, but rather a decreased constitutive expression of 
DC-SIGN in immature DCs, suggesting that the modulation of 
the epithelial environment is specific to monocytes. To confirm 
the role of the epithelial environment, CM obtained from pri-
mary nasal epithelial cells (PNECs) or primary alveolar epithelial 
cells (PAECs) were compared with monocytes cultured in their 
respective epithelial media. As shown in Figures 1E–G, BEC-CM 
significantly increased the expression of CD141, CD123, and 
DC-SIGN. PAEC-CM has been shown to increase the expression 
of CD141 and CD123. In contrast, PNEC-CM only increased 
CD141 expression, suggesting that CD123 is a receptor that 
may play a role in the airways within the bronchial or alveolar 
environment. DC-SIGN seems to be a receptor only modulated 
by the bronchial environment. In contrast, CD141 seems to be a 
receptor modulated by the epithelial environment regardless of 
the epithelial origin. As a control, monocytes were cultured in 
BEC-CM obtained from primary lung endothelial cells or fibro-
blasts, and none of these conditions upregulated the expression of 
these receptors as shown in Figure S1 in Supplementary Material. 
These results confirm that the epithelium specifically modulates 
a CD141 phenotype in monocytes and is not restricted to the 
epithelial BEAS 2B cell line. CD123/CD-SIGN modulation may 
depend on the local environment.
Bec-cM Upregulates expression  
of FLT3 in Monocytes
To address whether BEC-conditioned monocytes are related to 
ModDCs, we analyzed the expression of a group of genes involved 
in DC and ModDC development (22, 31, 32), which includes 
FcεR1α, XCR1, CSF1R, FLT3, IRF4, and ZBTB46 (Figures 2A–F). 
Monocytes were cultured with medium alone or with BEC-CM 
for 24 or 48 h. For comparative purposes, we also analyzed the 
gene expression in DCs or macrophages. Consistent with previ-
ous reports, DCs expressed the highest levels of the transcription 
factors, ZBTB46 and IRF4, and the receptors, FcεR1α and CSF1R 
(Figures  2A,C,E,F). Monocytes expressed high levels of XCR1 
and intermediate levels of CSF1R and IRF4, compared to DCs. 
However, their expression was not further increased by BEC-CM 
(Figures  2B,C,F). Importantly, BEC-CM upregulated the 
expression of FLT3 and the modulation was already high at 24 h 
(Figure  2D). In contrast, macrophages only expressed CSF1R, 
a growth factor receptor involved in macrophage development 
(Figure 2C). These results suggest that monocyte development 
closely resembles that of DCs. The fact that BEC-CM is able to 
increase the expression of FLT3, a receptor involved in DC differ-
entiation and maintenance in the periphery (33), suggests that the 
bronchial epithelium participates in the transition of monocytes 
toward a ModDC phenotype.
Bec-cM stimulated the secretion  
of il-1β, il-6, and il-10 by Monocytes
Next, to investigate whether endogenous molecules produced by 
BEC-CM were capable of activating monocytes, IL-10, IL-6, IL-1β, 
IL-23, IL-12p70, and TNF-α were analyzed after 48 h of cultur-
ing monocytes in BEC-CM. Indeed, as show in Figures 3A–D, 
BEC-CM induced the release of IL-1β, IL-6, and IL-10 by 
monocytes. The observed release of cytokines corresponds to the 
cytokines released by monocytes because, as shown in Figure S2 
in Supplementary Material, in basal culture conditions, BECs did 
not release IL-1β, IL-10, and lower levels of IL-6. The release of 
IL-12p70 and TNF-α were not modulated by BEC-CM (data not 
shown). These results suggest that endogenous molecules released 
constitutively by BECs are already sufficient in order to induce 
specific phenotypic and functional modifications of monocytes.
Bec-conditioned Monocytes efficiently 
Trigger the Differentiation of human Th17 
cells through a Mechanism involving 
il-1β, but also stimulate Memory cells to 
Produce il-10
Based on the observation that monocytes cultured in BEC-CM 
released pro-Th17 cytokines, such as IL-1β and IL-6, we asked whether 
or not BEC-conditioned monocytes were capable of priming an 
inflammatory response, such as Th17 or Th1 responses or of stimu-
lating memory cells to produce IL-10. For these experiments, mono-
cytes were cultured with medium alone or with BEC-CM for 48 h. 
Subsequently, cells were washed and then cocultured with allogenic 
naive or memory T cells for 7 days and then supplemented with IL-2 
for two additional days. During the co-culture, monocytes cultured 
in BEC-CM were able to increase the release of IL-17 in naive T-cells 
while maintaining a strong Th1 response through the release of IFN-γ 
(Figures 4A,B). This result contrasts with that of memory T cells, in 
which BEC-conditioned monocytes mostly favored the induction of 
FigUre 1 | continued
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FigUre 2 | expression of monocyte-derived Dc markers in bronchial epithelial cell-conditioned monocytes. Monocytes were cultured for 24 or 48 h with 
medium alone or with Bronchial epithelial cell-conditioned media (BEC-CM). Gene expression of (a) FcεR1α, (B) XCR1, (c) CSF1R, (D) FLT3, (e) ZBTB46 and  
(F) IRF4 were assessed by the real-time quantitative PCR. Data express the relative gene abundance normalize to the endogenous control β-2-microglobulin (B2M) 
and are shown as mean ± SEM of four to six independent experiments, done in duplicates. Statistical analysis was performed using analysis of variance test 
(followed by Tukey multiple comparisons test) (*P < 0.05).
FigUre 1 | continued  
Bronchial epithelial cell-conditioned media (Bec-cM) enhances the expression of cD141/cD123/Dc-sign on monocytes. (a) Phenotypic analysis of 
surface markers on monocytes cultured withBEC-CM. FACS analysis was performed on monocytes that were cultured for 48 h with medium alone or with BEC-CM. 
Representative histograms (thick lines) of the indicated antibody staining are plotted with the corresponding isotype controls (shaded histograms). All data were 
obtained with similar results in at least four independent experiments. (B–D) Dendritic cells (DCs) were obtained by culturing monocytes with GM-CSF (10 ng/mL)  
and IL-4 (10 ng/mL). Then, monocytes and DCs were cultured for 48 h with medium alone or with BEC-CM. Bar histograms of the mean fluorescence intensity 
(MFI) ratio calculated with its specific isotype for (B) CD141, (c) CD123, and (D) DC-SIGN. Data are expressed as means ± SEM of at least eight independent 
experiments for monocytes and at least five independent experiments for DCs. Statistical analysis was performed using analysis of variance test (ANOVA) (followed 
by Tukey multiple comparisons test) (*P < 0.05, **P < 0.01). (e–g) Monocytes were cultured for 48 h with BEC-CM, PNEC-CM, or PAEC-CM or with the 
corresponding control media 1:LHC-8, 2: PneumaCult™-ALI, 3: CELLnTEC. Data represent the MFI ratio calculated with its specific isotype for CD141 (e), CD123 
(F), and DC-SIGN (g). Data are expressed as means ± SEM of at least five independent experiments. Statistical analysis was performed using ANOVA (followed by 
Tukey multiple comparisons test), *P < 0.05, **P < 0.01.
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an anti-inflammatory response as measured by the release of IL-10 
(Figure 4C). BEC-conditioned monocytes to some extent induced 
the release of IL-17, albeit not significantly. To further document 
the function of BEC-CM, and hence the role of IL-1β and IL-6 in 
the ability of BEC-CM-monocytes to polarize naive T  cells into 
Th17  cells, we evaluated the effects of anti-IL-1β and anti-IL-6 
receptor (IL-6R) neutralizing antibodies during the allo-reaction. 
Treating IL-1β or IL-1β and IL-6R with neutralizing antibodies 
abolished the release of IL-17 by naive T-cells (Figure 4D). These 
results indicate that the ability of monocytes cultured in BEC-CM 
to induce IL-17 release is critically dependent on the production 
of IL-1β and on the synergistic effect of IL-6 with IL-1β, but is 
not dependent on IL-6 alone. Overall, these results demonstrate 
that BEC-CM has an important capacity to modulate monocyte 
function, resulting in distinct T-helper responses, such as a strong 
inflammatory response when the monocytes encounter a naive 
T cell, but a more anti-inflammatory response when they encounter 
a memory T cell.
FigUre 3 | Bronchial epithelial cell-conditioned media (Bec-cM) 
stimulates the secretion of il1β, il-6, and il-10 in monocytes. 
Monocytes were cultured for 48 h with medium alone or with BEC-CM. 
The secretion of cytokines was analyzed using the Luminex system or ELISA: 
(a) IL-1β, (B) IL-6, (c) IL-23, and (D) IL-10. Data are expressed as 
means ± SEM of at least four independent experiments. Statistical analysis 
was performed using Mann–Whitney test (*P < 0.05, **P < 0.01).
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Bec-cM Differentially regulates the 
release of cytokines by Monocytes  
and Dcs after lPs Treatment
To better characterize the role of the epithelium-soluble compo-
nents on monocyte function, monocytes and DCs were cultured 
with medium alone or with BEC-CM for 24  h and further 
stimulated with LPS (100 ng/mL). The release of the cytokines 
IL-12p70, IL-10, TNF-α, IL-6, IL-1β, and IL-23 was analyzed after 
24 h of LPS stimulation. As shown in Figures 5A–F, monocytes 
stimulated by LPS released IL-10, TNF-α, and IL-6, but no 
significant amounts of IL-1β or IL-23 and no IL-12p70 at all. 
BEC-conditioned monocytes released IL-10 and TNF-α after LPS 
stimulation as did the monocytes alone. As mentioned previously, 
BEC-conditioned monocytes are able to produce IL-6, IL-1β, 
and IL-10, but upon LPS stimulation only the release of IL-6 and 
IL-10 were further increased (Figures 5B,D,E). In regard to DCs 
and in line with previously published results (5, 34), BEC-CM 
abrogated the release of the inflammatory cytokines IL-12p70, 
IL-10, TNF-α, and IL-23 and caused a partial reduction of IL-6 in 
LPS-stimulated DCs. Overall, these results highlight the distinct 
inflammatory response induced by the epithelial-conditioned 
environment which promotes an inflammatory state in mono-
cytes, but maintains a strong immunosuppression on DCs.
ligation of cD141 on Monocytes in the 
Bec-cM environment suppresses the 
release of TnF-α when stimulated by lPs
As shown in Figure 1B, the CD141 receptor appears to be spe-
cifically modulated by BEC-CM. Thus, in order to understand 
the role of CD141 in the monocyte inflammatory response, 
monocytes were cultured with medium alone or with BEC-CM 
in the presence or absence of anti-CD141 for 24  h and were 
further stimulated for 24 h with LPS. As shown in Figure 6, liga-
tion of CD141 did not significantly modulate the LPS-induced 
release of IL-10, IL-6, or IL-1β in cells cultured in media alone or 
BEC-CM (Figures 6A–D). However, ligation of CD141 specifi-
cally abrogated the release of TNF-α only in the BEC environ-
ment (Figure 6B), suggesting that CD141 downstream signaling 
events impact LPS-induced TNF-α expression or release, and 
this pathway can be blocked by the synergistic effect of CD141 
activation and epithelial soluble components.
inflammatory cytokines Boosted the 
expression of cD141 in Monocytes 
cultured in Bec-cM, but Do not  
Modulate FLT3 expression
With the aim to mimic sterile inflammation and hence determine 
whether inflammatory cytokines directly modulate the CD141/
CD123/DC-SIGN phenotype and expression of IL-1β and FLT3, 
monocytes were cultured with medium alone or with BEC-CM 
supplemented with IL-6 (100 pg/mL) and IL-8 (500 pg/mL) at 
concentrations that were found to be produced by ECs in basal 
culture conditions (Figure S2 in Supplementary Material) or 
cultured with an inflammatory cocktail composed of 1  ng/mL 
of IL-6, IL-8, IL-1β, IL-15, TNF-α, and GM-CSF cytokines 
produced by ECs during inflammation (35). As shown in 
Figures 7A–E, IL-6 and IL-8, in basal conditions, were not suf-
ficient to induce the modulation of the CD141/CD123/DC-SIGN 
phenotype or the IL-1β and FLT3 expression on monocytes. In 
contrast, the inflammatory cocktail modulated the expression 
of DC-SIGN and CD123 in monocytes and CD123 expression 
was further increased by BEC-CM (Figure  7B). CD141 recep-
tors on monocytes showed a different modulation. CD141 was 
not significantly upregulated by inflammatory cytokines in 
monocytes alone, but the expression of CD141 was boosted in 
monocytes cultured in BEC-CM (Figure  7A). Regarding FLT3 
and IL-1β expression, both were significantly modulated by the 
BEC-CM. The inflammatory cocktail was sufficient to modulate 
the expression of IL-1β in monocytes, although FLT3 expression 
is independent of the inflammatory conditions. Overall, these 
results highlight how endogenous molecules, such as cytokines, 
differentially regulate the phenotype and function of monocytes 
in which CD123, DC-SIGN, and IL-1β showed to be directly 
modulated by inflammation. Of particular interest, modulation 
of CD141 seems to require a synergistic effect between cytokines 
and other endogenous molecules produced by BECs and FLT3, 
which are not modulated explicitly by inflammation. None of the 
other ModDC genes were modulated by inflammatory cytokines 
(data not shown).
FigUre 4 | Monocytes cultured in bronchial epithelial cell-conditioned media (Bec-cM) have an increased ability to trigger the differentiation of 
human naive T cells into il-17 producers. Allogenic Naive T cells or Memory T cells were stimulated with conditioned monocytes [cultured with medium alone or 
with BEC-CM (BEC-cMo)] at a monocyte:T-cell ratio of 1:10 for 9 days, supplemented with IL-2 for the last 2 days and then stimulated for 5 h with PMA and 
ionomycin. Supernatants were analyzed for the release of (a) IL-17, (B) IFN-γ, and (c) IL-10. Data are expressed as means ± SEM of four to six independent 
experiments. Statistical analysis was performed using a Mann–Whitney test (*P < 0.05). (D) Production of IL-17 by naive T-cells primed with allogenic monocytes 
that were cultured with medium alone or with BEC-CM at a monocytes:T-cell ratio of 1:10. During the mixed lymphocyte reaction, cells were cultured in the 
presence of neutralizing antibodies to IL-1β, IL-6R, or both. Data are expressed as mean ± SEM of three independent experiments. Statistical analysis was 
performed using analysis of variance test (followed by Tukey multiple comparisons test) (*P < 0.05, **P < 0.01).
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The cD141/cD123/Dc-sign Phenotype 
can Be Found in the BalF of Patients  
with sarcoidosis
In order to determine whether the expression of CD141/CD123/
DC-SIGN is biologically significant, and hence to identify a spe-
cific population in the lung, we analyzed cells from the BALF of 
patients with two distinct lung diseases: sarcoidosis and intersti-
tial pneumonia. Furthermore, we had the opportunity to analyze 
some BALF from patients who had developed adenocarcinoma 
in which no clinical inflammation or development of infection 
could be found. Cells obtained from BALF were stained using 
a combination of phenotypic markers found on monocytes, 
macrophages, and DCs (Figures  8A–E). After the exclusion of 
cells gated as lin− (R2) and doublets (R3), live cells were gated 
by HLA-DR expression and further selected by their CD11b 
expression with the aim of differentiating classical DCs from 
monocytes. Then, cells were further selected by their expres-
sion of CD14+ and CD16+, and we evaluated the expression of 
the CD141/CD123/DC-SIGN triple-positive cell in each of the 
four gates generated. In Figure  8B, expression of the surface 
molecules CD141, CD123, and DC-SIGN is depicted. It is worth 
mentioning that the frequency of CD11b and CD14/CD16 cells 
was similar in all patients (Figure S3 in Supplementary Material). 
As we can observe in Figure 8C, a triple-positive population can 
be found in the HLA-DR+, CD11b+, CD14+, CD16− gate in all 
patients. It was expressed at low frequency (2.3% mean ±  0.4 
SEM) in patients with adenocarcinoma, slightly increased in 
patients who had developed lung fibrosis (4.6% mean  ±  1.5 
SEM), and was significantly increased in patients with pulmonary 
sarcoidosis (11.2% mean ± 2.4 SEM), which is a disease with a 
lymphocytic inflammatory pattern (28). This is a key observation 
as it demonstrates that the CD141/CD123/DC-SIGN population 
can be associated with inflammation and may play a role in the 
pathogenesis of sarcoidosis. Moreover, as shown in Figures 8D,E, 
this population also expresses CD1c and CD163, but not CD1a, 
and additionally stained positive for IRF-4, a transcriptional fac-
tor expressed in bona fide migratory DCs. Overall, these results 
suggest that the population expressing CD141/CD123/DC-SIGN 
resembles monocyte-derived DCs and, in sarcoidosis, may be a 
subset related to inflammatory DCs.
DiscUssiOn
Little is known about the role of the epithelium modulating mono-
cyte function upon arrival in the lung parenchyma. In the present 
study, we demonstrate that bronchial epithelial conditioned 
FigUre 5 | Bronchial epithelial cell-conditioned media (Bec-cM) regulates the release of cytokines by monocytes and dendritic cells (Dcs) 
differentially after lipopolysaccharide (lPs). Monocytes and DCs were cultured for 48 h with medium alone or with BEC-CM. Cells were stimulated with LPS 
(100 ng/mL) for the last 24 h. The secretion of cytokines was analyzed using the Luminex system or ELISA: (a) IL-12p70, (B) IL-10, (c) TNF-α, (D) IL-6, (e) IL-1β, 
and (F) IL-23. Data are expressed as means ± SEM of at least four independent experiments. Statistical analysis was performed using analysis of variance test 
(followed by the Fisher LSD test) (*P < 0.05, **P < 0.01).
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media (BEC-CM) favors, on monocytes, the release of IL-10 and 
IL-6, but particularly the expression and release of IL-1β, thus 
resulting in the induction of naive Th17 cells and IL-10-producer 
memory T cells. This particular phenotype is characterized by the 
surface expression of CD141/CD123/DC-SIGN and FLT3 gene 
expression and may represent ModDCs.
Our results show that monocytes express XCR1, IRF4, and 
CSF1R, molecular features described in ModDC development 
as part of the DC and macrophage signatures. However, their 
expression is not further increased by BEC-CM. FLT3 expres-
sion is low in monocytes, whereas it is upregulated by BEC-CM, 
thus establishing a close link to DC development, since it has 
been demonstrated that FLT3L is a pivotal growth factor in the 
maintenance of DC homeostasis in peripheral lymphoid tissues 
in the steady state (36). ZBTB46 and FcεRIα gene expression was 
not modulated by BEC-CM, and none of the genes analyzed were 
significantly modulated by inflammatory cytokines. This suggests 
that to fully commit monocytes to become inflammatory DCs, 
they may require additional signals.
In our study, IL-1β played a key role. It was surprising that 
BEC-CM, without microbial stimulus, was capable of inducing 
the release of IL-1β by monocytes but not by DCs. BEC-CM 
induced the expression and release of IL-1β, thus supporting a 
one-step model for IL-1β secretion. Recent studies demonstrated 
that, in human monocytes, IL-1β can be secreted by an “alterna-
tive inflammasome pathway,” which is distinct from classical 
inflammasome activation and does not require a second stimulus 
(37). Moreover, it has been reported that a variety of endogenous 
molecules can also signal, through pattern recognition receptors, 
the induction of IL-1β secretion (38). In view of these results, we 
hypothesized that cytokines released by ECs are at the origin of the 
expression and release of IL-1β. As we reported previously (35) 
and as is shown in Figure S2 in Supplementary Material, BECs 
constitutively release cytokines and chemokines, which constitute 
basal level conditions. Our results show that IL-6 and IL-8, the 
major cytokine components of the basal culture condition, were 
not sufficient to modify the expression of IL-1β on monocytes. 
In future experiments, we will analyze other components of ECs 
FigUre 6 | ligation of cD141 in the bronchial epithelial cell-conditioned media (Bec-cM) environment suppresses the release of TnF-α when 
stimulated by lipopolysaccharide (lPs). Monocytes were cultured for 48 h with medium alone or with BEC-CM in the presence of the anti-CD141 antibody 
(0.5 µg/mL) or 0.5 µg/mL mouse IgG1 isotype control. Cells were stimulated with LPS (100 ng/mL) for the last 24 h. The secretion of cytokines was analyzed using 
the Luminex system: (a) IL-10, (B) TNF-α, (c) IL-6, and (D) IL-1β. Data are expressed as means ± SEM of at least five independent experiments. Statistical analysis 
was performed using analysis of variance test (followed by the Fisher LSD test) (*P < 0.05).
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which are known to have immune regulatory functions, such 
as nitric oxide, and lipid mediators, such as prostaglandin-E2 
(6, 39, 40).
Our in vitro experiments show that BEC-conditioned mono-
cytes are also capable of expanding both naive and memory 
human T helper cells, although each with a different phenotype. 
On one hand, BEC-conditioned monocytes were able to polarize 
naive CD4 T cells toward Th1/Th17 cells with a low level of IL-10 
production. On the other hand, BEC-conditioned monocytes 
were also able to expand memory CD4 T cells that had a regula-
tory phenotype instead by the marked production of IL-10 and 
to some extent, albeit not significantly, IL-17. There is increasing 
evidence about the existence of pathogenic and non-pathogenic 
Th17 (41). It has been reported that the cellular response to IL-23, 
not IL-17 itself, is the major factor driving pathogenic Th17 (42). 
The fact that IL-23 is not a cytokine produced by BEC-conditioned 
monocytes even upon LPS stimulation, leads us to believe that, in 
tissues where a BEC-conditioned monocyte encounters a memory 
T cell, it will have a specific role in homeostatic immune function 
and if there is any IL-17 induced it will then be more protective, 
e.g., against a fungal infection. Nevertheless, BEC-conditioned 
monocytes are able to prime naive T cells into a more inflam-
matory IL-17/IFN-γ phenotype in which only the inhibition of 
IL-6 in combination with IL-1β, or of IL-1β alone, were critically 
important for the expansion of Th17. To what extent the IL-17 
induced by BEC-conditioned monocytes in basal conditions or 
during inflammation is pathogenic or non-pathogenic will be 
explored in future studies.
Another important aspect of our studies is the demonstration 
of the different specificities of BEC-CM on activation of mono-
cytes and DCs. DCs cultured in BEC-CM developed an anti-
inflammatory phenotype where the release of IL-12p70, IL-23, 
TNF-α, and IL-10 upon LPS stimulation was impaired. These 
results are largely supported by previous studies in which the 
epithelial environment generated by lung or intestinal ECs gener-
ates DCs with regulatory features (4–6, 43). In contrast, upon LPS 
stimulation, BEC-conditioned monocytes preserved the release 
of cytokines, thus maintaining the innate inflammatory response. 
Overall, our data depict a distinct, cell-specific modulation and 
regulatory function by BEC-CM on monocytes and DCs.
The functions of CD123 and DC-SIGN have been well 
documented in the past few years (44, 45); however, the role that 
the thrombomodulin receptor CD141 may play in the context 
of monocyte and DC modulation remains unknown. In our 
experiments, CD141 is a receptor shown to be upregulated by 
ECs localized in the lower or upper respiratory tract. Ligation 
of CD141 on monocytes in the bronchial epithelial environment 
blocked the LPS-mediated release of TNF-α, suggesting that this 
receptor may be involved in the inhibition of a TNF-inflammatory 
axis during LPS inflammation. However, CD141 did not show 
any modulation upon LPS stimulation (data not shown). In 
contrast to CD141, DC-SIGN, a pattern recognition receptor, 
FigUre 7 | inflammatory cytokines boosted the expression of cD141 in monocytes cultured in bronchial epithelial cell-conditioned media (Bec-cM). 
Monocytes were cultured for 48 h (a–c) or 24 h (D,e) with medium alone or with BEC-CM. Cells were supplemented with IL-6 (100 pg/mL) and IL-8 (500 pg/mL) 
designated as the basal condition or with 1 ng/mL of the following cytokines: IL-6, IL-8, IL-15, IL-1β, GM-CSF, and TNF-α, designated as the inflammatory cocktail. 
The mean fluorescence intensity ratio calculated with its specific isotype for the expression of (a) CD141, (B) CD123, and (c) DC-SIGN is plotted. Data are 
expressed as means ± SEM of eight independent experiments (*P < 0.05). Statistical analysis was performed using analysis of variance test (ANOVA) (followed by 
Tukey multiple comparisons test). Gene expression of (D) IL-1β and (e) FLT3 were assessed by real-time quantitative PCR. Data express the relative gene 
abundance normalized to the endogenous control β-2-microglobulin (B2M) and are shown as mean ± SEM of three to six independent experiments, performed in 
duplicate. Statistical analysis was performed using ANOVA (followed by Tukey multiple comparisons test) (*P < 0.05, **P < 0.01).
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was not modulated by PNEC-CM or PAEC-CM. This result was 
unexpected with PAEC-CM since the alveolar environment is a 
key location for the neutralization of invading pathogens. Our 
result is supported, however, by previous studies, which showed 
that monocytes cultured in CM, from the alveolar cell line A-549 
from mock or respiratory syncytial virus CM, do not upregulate 
this receptor (35). In future studies, we will explore to what 
extent alveolar ECs specifically modulate DC-SIGN expression 
in macrophages but not in monocytes (46).
Over the past decades, the host immune response to micro-
organisms has been extensively studied. However, for several 
chronic lung diseases, such as sarcoidosis and idiopathic pul-
monary fibrosis, for which the etiology and pathogenesis are still 
unknown, endogenous signals, such as cytokines, growth factors, 
proteases and, in general, damage-associated molecular pattern 
molecules resulting from recurrent injury, are highly correlated 
to the loss of lung function and in some cases to the mainte-
nance of chronic inflammation (47, 48). To gain insight into 
the modulation of BEC-conditioned monocytes during sterile 
inflammation, BEC-CM was supplemented with inflammatory 
cytokines. Inflammatory cytokines modulated the expression 
of CD141/CD123/DC-SIGN receptors with different kinetics. 
FigUre 8 | identification of the cD141/cD123/Dc-sign phenotype in bronchoalveolar lavage fluid (BalF). Cells from BALF were obtained from patients 
with lung adenocarcinoma (n = 4), sarcoidosis (n = 13), or interstitial pneumonia (n = 7). Cells were stained with anti-lineage (Lin) (CD3, CD19, CD 56), HLA-DR, 
CD11b, CD14, CD16, CD141, CD123, and DC-SIGN antibodies and analyzed by flow cytometry. (a,B) One representative experiment out of 13 samples from 
sarcoidosis patients is shown. Total cells were gated as depicted. From the FSC/SSC R1 gate, cells were gated into lin− and live cells (R2) and doublets exclusion 
(R3). Then cells were gated by HLA-DR expression and further selected by CD11b expression. (B) Histograms display the expression of the surface molecules 
CD141, CD123, and DC-SIGN of the gated population Lin−, HLA-DR+, CD11b+, CD14+, and CD16− in a sarcoidosis patient compared with the corresponding 
isotype control. (c) Percentage of the triple-positive CD141/CD123/DC-SIGN population among Lin− HLA-DR+ and subsequent analysis in CD11b and CD14/CD16 
gates. Data are depicted in box-and-whisker graph (*P < 0.05, **P < 0.01). Statistical analysis was performed using Two-way analysis of variance test (followed by 
Tukey multiple comparisons test). (D,e) Cell percentage and representative histograms of CD1c, CD1a, CD163, and intracellular IRF4 in the Lin− HLA-DR+CD11b+ 
CD14+CD16− population. Data are expressed as means ± SEM of at least four BALF with sarcoidosis.
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They sufficiently upregulated CD123 and DC-SIGN receptors 
in monocytes, but not CD141. Indeed, a synergistic effect was 
observed for CD141 expression as it was particularly upregulated 
in the epithelial environment, suggesting that inflammatory 
cytokines with unknown endogenous signals have a synergistic 
effect on CD141 expression. Based on our results, CD141/
CD123/DC-SIGN is a phenotype modulated by BEC-CM under 
basal culture conditions. Moreover these receptors were further 
upregulated during sterile inflammation and they were also 
shown to be upregulated after viral-infected BEC-CM (Figure S4 
in Supplementary Material). We hypothesized that during 
inflammation the frequency of the CD141/CD123/DC-SIGN 
population increases in vivo.
Thus, we addressed whether this specific CD141/CD123/
DC-SIGN phenotype can be found in  vivo and whether this 
phenotype correlates with an inflammatory state. Multicolor 
flow cytometry was performed in cells obtained from the 
BALF of patients with different lung diseases. As expected, we 
found CD141/CD123/DC-SIGN triple-positive monocytes in 
the HLA-DR+CD11b+CD14+D16− fraction. The fact that the 
triple-positive population was present at low frequency (2.3% 
mean  ±  0.4 SEM) in patients with adenocarcinoma, slightly 
increased in patients who had developed a lung fibrosis (4.6% 
mean ± 1.5 SEM), and significantly increased in patients with 
pulmonary sarcoidosis (11.2% mean ± 2.4 SEM) suggests that 
the frequency of this phenotype could be related to inflamma-
tion, since in patients who had developed adenocarcinoma, there 
were no signs of clinical inflammation or infection. In regard to 
the fibrotic environment, which is characterized by the expres-
sion of fibrotic cytokines, e.g., TGFβ-1 (49, 50), the CD141/
CD123/DC-SIGN population seems not to be significantly 
involved. However, sarcoidosis, a disease characterized by the 
formation of granulomas and increased numbers of lympho-
cytes and inflammatory mediators, such as IL-12 and TNF-α 
but also IL-10 (28, 48, 51), was associated with an increased 
frequency of the CD141/CD123/DC-SIGN population. Further 
investigation is required in order to determine the role that this 
population can play in each of the lung diseases, particularly 
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in inflammation. Furthermore, it is essential to determine the 
role of the  epithelium in vivo and whether or not a dysregulated 
function is responsible for the accumulation of this particular 
population during inflammation.
It has been very recently described that a ModDC subset 
may exist in humans (21, 22, 52, 53). Two recent papers have 
identified a particular subset of monocytes expressing HLA-
DR+CD14+CD16− CD206+CD1c+ with variable levels of CD1a in 
BALF and lung tissues at steady state (21). Baharom et al. described 
a similar subset of ModDCs on the basis of IRF4 expression (53). 
However, there is disagreement in regard to the expression of 
CD141. Baharom et  al. mentioned that this HLA-DR+CD14+ 
CD16−CD206+ population also upregulates CD141. In contrast, 
Desch et  al. classified the HLA-DR+CD14+CD141+DC-SIGN+ 
population as tissue monocytes. This discrepancy may be due 
to differences in gate strategy since Desch et  al. included both 
CD16high and CD16−/low fractions in their analysis. Our analysis 
demonstrated that the CD141/CD123/DC-SIGN population 
in the HLA-DR+ CD14+ CD16− fraction also expresses CD1c. 
Whether the CD14+CD1c+ (HLA-DR+CD16−CD206+) popula-
tion, as described by previous reports at steady state and the 
CD141/CD123/DC-SIGN (HLA-DR+CD14+ CD16−CD1c+D1a−) 
population, as reported in this study, are different subsets or are 
cells with the same origin but in different phases of development 
(from steady state to inflammation), has to be further studied. 
What is noteworthy and highlights the significance of the 
correlation of our triple-positive cells with ModDCs, is that at 
steady state in axillary and pulmonary lymph nodes (LNs), in 
addition to the classical DCs (pDCs, CD141-DCs, CD1c-DCs 
CD1a and Langerhans), one additional population was identi-
fied: the CD141+CD14+ population, which also expresses HLA-
DR+CD11c+CD206+ (21, 52). The studies performed in axillary 
LN reported that this population also expresses DC-SIGN and 
suggest that it is a migratory skin DC subset (52). We speculate 
that the CD141/CD123/DC-SIGN triple population might 
be a migratory ModDC subset, on the basis of the phenotype 
expressed, but also, based on its expression of IRF4, a transcrip-
tional factor, which is known to play a role in the migration of 
peripheral tissue DCs (31).
In summary, our results contribute to the understanding 
of the mechanism by which BECs modulate local immune 
responses. Soluble components of the epithelium promoted a 
particular CD141/CD123/DC-SIGN phenotype in monocytes 
thus inducing the expression of the FLT3 gene making this 
phenotype resemble that of ModDCs. Functionally, BEC-
conditioned monocytes, by releasing IL-6, IL-1β, and IL-10, 
are capable of inducing inflammatory Th17 responses, but 
also capable of inducing IL-10 producing memory T  cells. 
This highlights the specific immune regulation induced by the 
epithelium. The frequency of the CD141/CD123/DC-SIGN 
population is specifically increased in patients with sarcoidosis, 
an inflammatory lung disorder. Further investigation is needed 
in order to determine which epithelial endogenous signals are 
responsible for the induction of this particular phenotype and 
in order to decipher the mechanisms by which the CD141/
CD123/DC-SIGN/FLT3 monocytes tip the balance in favor of a 
pathogenic or non-pathogenic response.
eThics sTaTeMenT
PBMCs were isolated from the buffy coats of healthy donors. 
In accordance with the Cantonal Ethics Committee of the 
Canton of Vaud (Vaud-Switzerland), written consent from the 
donors was obtained from the Lausanne blood transfusion 
center. Human primary nasal epithelial cells (PNECs) were 
obtained from healthy volunteers. This study was carried out in 
accordance with the recommendations of the Cantonal Ethics 
Committee of the Canton of Bern, with written informed 
consent from all subjects. All subjects gave written informed 
consent in accordance with the Declaration of Helsinki. The 
protocol was approved by the Cantonal Ethics Committee 
of the Canton of Bern (Bern-Switzerland No. 1104). Human 
primary alveolar epithelial cells (PAECs) were cultured from 
the tissue of patients undergoing surgical lung resection due 
to lung cancer. This study was carried out in accordance with 
the recommendations of the Human Ethics Committee of 
Basel with written informed consent from all subjects. All 
subjects gave written informed consent in accordance with 
the Declaration of Helsinki. The protocol was approved by The 
Human Ethics Committee of Basel (EKBB # 05/06, Department 
of Pneumology, University of Basel, Switzerland).
Bronchoalveolar lavage fluid samples were obtained from 
patients undergoing bronchoscopy for medical reasons by the 
CHUV Pneumology Service. This study was carried out in 
accordance with the recommendations of the Cantonal Ethics 
Committee of the Canton of Vaud with written informed consent 
from all subjects. All subjects gave written informed consent in 
accordance with the Declaration of Helsinki. The protocol was 
approved by the Cantonal Ethics Committee of the Canton of 
Vaud (Vaud-Switzerland/ protocol 294/1).
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